Integration of Next-generation Sequencing and Immune Checkpoint Inhibitors in Targeted Symptom Control and Palliative Care in Solid Tumor Malignancies: A Multidisciplinary Clinician Perspective

Doron Feinsilber; Marco Ruiz; Sorin Buga; Leigh A Hatch; Andrew D. Hatch; Katrina A Mears

doi:10.7759/cureus.2909

Integration of Next-generation Sequencing and Immune Checkpoint Inhibitors in Targeted Symptom Control and Palliative Care in Solid Tumor Malignancies: A Multidisciplinary Clinician Perspective

Doron Feinsilber
, Marco Ruiz
, Sorin Buga
, Leigh A Hatch
, Andrew D. Hatch
, Katrina A Mears

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Cureus
Volume	10
DOIs	https://doi.org/10.7759/cureus.2909
State	Published - Jul 2 2018

Disciplines

Surgery
Critical Care
Medicine and Health Sciences

Access to Document

10.7759/cureus.2909License: Unspecified

Cite this

@article{eeb5eddf244c4a10ab3f49742c9cb676,

title = "Integration of Next-generation Sequencing and Immune Checkpoint Inhibitors in Targeted Symptom Control and Palliative Care in Solid Tumor Malignancies: A Multidisciplinary Clinician Perspective",

author = "Doron Feinsilber and Marco Ruiz and Sorin Buga and Hatch, \{Leigh A\} and Hatch, \{Andrew D.\} and Mears, \{Katrina A\}",

note = "The molecular characterization of solid tumor malignancies with respect to tumorgenesis, risk stratification, and prognostication of chemotherapeutic side effects is multi-faceted. Characterizing these mechanisms requires a detailed understanding of cytogenetics and pharmacology. In addition to the standard palliative care interventions that address issues such as fatigue, neuropathy, performance status, depression, nutrition, cachexia, anxiety, and medical ethics, we must also delve into individual chemotherapy side effects.",

year = "2018",

month = jul,

day = "2",

doi = "10.7759/cureus.2909",

language = "American English",

volume = "10",

journal = "Cureus",

}

TY - JOUR

T1 - Integration of Next-generation Sequencing and Immune Checkpoint Inhibitors in Targeted Symptom Control and Palliative Care in Solid Tumor Malignancies: A Multidisciplinary Clinician Perspective

AU - Feinsilber, Doron

AU - Ruiz, Marco

AU - Buga, Sorin

AU - Hatch, Leigh A

AU - Hatch, Andrew D.

AU - Mears, Katrina A

N1 - The molecular characterization of solid tumor malignancies with respect to tumorgenesis, risk stratification, and prognostication of chemotherapeutic side effects is multi-faceted. Characterizing these mechanisms requires a detailed understanding of cytogenetics and pharmacology. In addition to the standard palliative care interventions that address issues such as fatigue, neuropathy, performance status, depression, nutrition, cachexia, anxiety, and medical ethics, we must also delve into individual chemotherapy side effects.

PY - 2018/7/2

Y1 - 2018/7/2

UR - https://www.cureus.com/articles/10309-integration-of-next-generation-sequencing-and-immune-checkpoint-inhibitors-in-targeted-symptom-control-and-palliative-care-in-solid-tumor-malignancies-a-multidisciplinary-clinician-perspective

U2 - 10.7759/cureus.2909

DO - 10.7759/cureus.2909

M3 - Article

VL - 10

JO - Cureus

JF - Cureus

ER -

Integration of Next-generation Sequencing and Immune Checkpoint Inhibitors in Targeted Symptom Control and Palliative Care in Solid Tumor Malignancies: A Multidisciplinary Clinician Perspective

Disciplines

Access to Document

Other files and links

Cite this